Efficacy and Safety of the Biosimilar Recombinant Human  Parathyroid Hormone Cinnopar® in Postmenopausal  Osteoporotic Women: A Randomized Double-blind Clinical Trial
DOAJ (DOAJ: Directory of Open Access Journals)